# INLURIYO
> **NDA218881** · New Drug Application · Sponsor: ELI LILLY AND CO · Approved 2025-09-25
## Drug
- **FDA Application Number:** NDA218881
- **Application type:** New Drug Application
- **Brand name:** INLURIYO
- **Generic name:** IMLUNESTRANT
- **Active ingredients:** IMLUNESTRANT TOSYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ELI LILLY AND CO
- **Manufacturer:** Eli Lilly and Company
- **First approval:** 2025-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218881)
---
*MORVS · CC0 1.0*